Overview

Pharmacokinetic Study on Raltegravir and Lamotrigine

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether interactions between raltegravir and lamotrigine take place and to study the safety of the combination raltegravir/lamotrigine before used in HIV patients.
Phase:
Phase 1
Details
Lead Sponsor:
Radboud University
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Anticonvulsants
Lamotrigine
Raltegravir Potassium